AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Engineered Antibodies Accelerating Drug Discovery And Development Conference Rescheduled.

Vaccine Weekly

| October 24, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 OCT 24 - (NewsRx.com & NewsRx.net) -- The world antibodies research community will be convening in Philadelphia, Pennsylvania, on October 22-23, 2001, to attend, speak, and exhibit at "Engineered Antibodies Accelerating Drug Discovery and Development" conference which was rescheduled after the events of September 11, 2001, announced Strategic Research Institute.

The conference and exposition was originally scheduled for September 18-19, 2001. The quality and integrity of the agenda has been preserved with several new additions. To request the agenda, please contact Ed Drilon at edrilon@srinstitute.com.

The conference, ...

Related articles from newspapers, magazines, journals, and more
AVANIR Pharmaceuticals' Subsidiary, Xenerex Biosciences, Demonstrates...
Press release article from: PR Newswire October 23, 2001 700+ words
...the Strategic Research Institute's annual Engineered Antibodies Conference yesterday afternoon in Philadelphia...in the future." The conference, titled Engineered Antibodies Accelerating Drug Discovery and Development, was organized...
Engineered Antibodies Conference & Exposition to be Held September 18-19 in...
Press release article from: PR Newswire May 1, 2001 700+ words
...community will be convening in Philadelphia on September 18-19 to attend, speak, and exhibit at "Engineered Antibodies Accelerating Drug Discovery & Development," announces Strategic Research Institute. The conference, focused...
Antigen-Targeted Antibody-Based Therapies to Be Featured at Engineered...
Press release article from: PR Newswire May 15, 2001 700+ words
...immunotherapeutic agents for the treatment of certain late-stage cancers will be featured on September 18-19 "Engineered Antibodies Accelerating Drug Discovery & Development" conference in Philadelphia, announces Strategic Research Institute...
Antigen-Targeted Antibody-Based Therapies to be Featured at Engineered...
Press release article from: PR Newswire June 6, 2001 700+ words
...immunotherapeutic agents for the treatment of certain late-stage cancers will be featured on September 18-19 "Engineered Antibodies Accelerating Drug Discovery & Development" conference in Philadelphia, announces Strategic Research Institute...
Study data from University of Melbourne update knowledge of engineered...
Newspaper article from: Blood Weekly March 12, 2009 700+ words
...plaques," scientists in Australia report (see also Engineered Antibodies). "The 4 kDa Abeta peptide (39-43 amino acids...Oxford OX2 6DP, England. Keywords: Australia, Engineered Antibodies, Alzheimer Disease, Amino Acids, Bioengineering...
Engineered Antibodies Conference to be Represented by over a Hundred Leading...
Press release article from: PR Newswire July 30, 2001 700+ words
...world industrial antibody community will be convening in Philadelphia, PA on September 18-19, to attend "Engineered Antibodies Conference & Exposition". The meeting is distinguished by the high quality presentations and recent...
Engineered Antibodies Conference to Feature Top Exhibiting Companies at...
Press release article from: PR Newswire July 12, 2001 700+ words
...tier players in the development of antibody technologies, are several of the first exhibitors to attend "Engineered Antibodies Conference & Exposition" on Sept 18-19 in Philadelphia, PA, announces Strategic Research Institute...
Cancer Therapeutic Leader Immunogen to Speak at Engineered Antibodies...
Press release article from: PR Newswire July 24, 2001 700+ words
...amp; Abgenix, will take part in section one headlined Post Genomic Antibody R & D in September's "Engineered Antibodies Conference & Exposition" on Sept 18-19 in Philadelphia, PA, announces Strategic Research Institute...
AltaRex Presents Foreign Antibody Approach and OvaRex(R) Clinical Data at...
Press release article from: PR Newswire October 23, 2001 700+ words
...Mass., Oct. 23 /PRNewswire/ -- AltaRex Corp. (AXO.TO, ALXFF.OTC) is presenting today at the Engineered Antibodies conference "Accelerating Drug Discovery and Development" at the Park Hyatt Philadelphia. The Conference...
PRESS RELEASE: AltaRex presents foreign antibody approach and OvaRex clinical...
News wire article from: Chemical Business Newsbase October 29, 2001 700+ words
AltaRex Corp is presenting at the Engineered Antibodies Conference "Accelerating Drug Discovery and Development" at the Park Hyatt Philadelphia. The Conference brings together top...
For more facts and information, see all results

Source: HighBeam Research, Engineered Antibodies Accelerating Drug Discovery And Development...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA